Glenmark Life Sciences IPO vs Nuvoco IPO

Comparision between Glenmark Life Sciences IPO and Nuvoco IPO.

IPO Details

Glenmark Life Sciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Nuvoco IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Glenmark Life Sciences IPO	Nuvoco IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Bofa Securities India Limited Bob Capital Markets Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Goldman Sachs (India) Securities Private Limited Kotak Mahindra Capital Company Limited SBI Capital Markets Limited	Axis Capital Limited Hsbc Securities & Capital Markets Pvt Ltd ICICI Securities Limited J.P. Morgan India Private Limited SBI Capital Markets Limited
Registrar	Kfin Technologies Limited	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Glenmark Life Sciences IPO is up to ₹1,513.60 Cr whereas the issue size of the Nuvoco IPO is up to ₹5,000.00 Cr. The final issue price of Glenmark Life Sciences IPO is ₹720.00 per share and of Nuvoco IPO is ₹570.00 per share.

	Glenmark Life Sciences IPO	Nuvoco IPO
Face Value	₹2 per share	₹10 per share
Issue Price (Lower)	₹695.00 per share	₹560.00 per share
Issue Price (Upper)	₹720.00 per share	₹570.00 per share
Issue Price (Final)	₹720.00 per share	₹570.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	20 shares	26 shares
Fresh Issue Size
Fresh Issue Size (Amount)	up to ₹1,060.00 Cr	up to ₹1,500.00 Cr
OFS Issue Size	63,00,000 shares
OFS Issue Size (Amount)	up to ₹453.60 Cr	up to ₹3,500.00 Cr
Issue Size Total
Issue Size Total (Amount)	up to ₹1,513.60 Cr	up to ₹5,000.00 Cr

IPO Timetable

Glenmark Life Sciences IPO opens on Jul 27, 2021, while Nuvoco IPO opens on Aug 09, 2021. The closing date of Glenmark Life Sciences IPO and Nuvoco IPO is Jul 29, 2021, and Aug 11, 2021, respectively.

	Glenmark Life Sciences IPO	Nuvoco IPO
Anchor Bid Date
Issue Open	Jul 27, 2021	Aug 09, 2021
Issue Close	Jul 29, 2021	Aug 11, 2021
Basis Of Allotment (Tentative)	Aug 03, 2021	Aug 17, 2021
Initiation of Refunds (Tentative)	Aug 04, 2021	Aug 18, 2021
Credit of Share (Tentative)	Aug 05, 2021	Aug 20, 2021
Listing date (Tentative)	Aug 06, 2021	Aug 23, 2021
Anchor Lockin End date 1	Sep 02, 2021	Sep 16, 2021
Anchor Lockin End date 2	Nov 01, 2021	Nov 15, 2021

Financials

Glenmark Life Sciences IPO P/E ratio is , as compared to Nuvoco IPO P/E ratio of .

Glenmark Life Sciences IPO

Nuvoco IPO

Financial

Summary of financial Information (Restated Consolidated)
Particulars	For the year/period ended (₹ in million)
	31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	19,970.75	17,256.04	14,753.95
Total Revenue	18,859.76	15,493.03	8,868.65
Profit After Tax	3,515.81	3,130.98	1,955.92

Summary of financial Information (Restated Consolidated)
Particulars	For the year/period ended (₹ in million)
	31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	1,99,075.70	134,443.22	132,617.03
Total Revenue	75,226.93	68,299.44	71,058.88
Profit After Tax	(259.19)	2,492.55	(264.88)

Promoter Shareholding (Pre-Issue)

100%

95.24%

Promoter Shareholding (Post-Issue)

82.84%

71.03%

P/E Ratio

Market Cap

ROE

ROCE

Debt/Equity

EPS

RoNW

Shares Offered

In the Glenmark Life Sciences IPO retail investors (RII) are offered 75,43,130 shares while in Nuvoco IPO retail investors are offered 75,43,130 shares. Qualified institutional buyers (QIB) are offered 42,42,379 shares in Glenmark Life Sciences IPO and 1,78,57,143 shares in Nuvoco IPO.

	Glenmark Life Sciences IPO	Nuvoco IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB	42,42,379 shares	1,78,57,143 shares
NII	32,32,770 shares	1,33,92,858 shares
RII	75,43,130 shares	3,12,50,000 shares
Employee	0 shares	0 shares
Others
Total	1,50,18,279 shares	6,25,00,001 shares

Bids Received (Subscription)

Glenmark Life Sciences IPO subscribed 44.17x in total, whereas Nuvoco IPO subscribed 1.71x.

	Glenmark Life Sciences IPO	Nuvoco IPO
QIB (times)	36.97x	4.23x
NII (times)	122.54x	0.66x
Big NII (times)
Small NII (times)
RII (times)	14.63x	0.73x
Employee (times)
Other (times)
Total (times)	44.17x	1.71x

Compare with others

Glenmark Life Sciences IPO	Nuvoco IPO
Nuvoco IPO	Krsnaa Diagnostics IPO
Rolex Rings IPO	CarTrade Tech IPO
Paytm IPO	Devyani International IPO
Tatva Chintan Pharma IPO	Windlas Biotech IPO
Zomato IPO	Exxaro Tiles IPO
Clean Science IPO	Rolex Rings IPO
G R Infraprojects IPO	Paytm IPO
India Pesticides IPO	Tatva Chintan Pharma IPO
Ruchi Soya FPO	Zomato IPO
KIMS IPO	Glenmark Life Sciences IPO

Comments

Add a public comment...